Spinal glial activation contributes to pathological pain states

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 5, 2008, Pages 972-983

  Cao, Hong ^a   Zhang, Yu Qiu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Allodynia; Astrocytes; Glial activation; Hyperalgesia; Microglia; Pathological pain; Proinflammatory cytokines

Indexed keywords

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; CASPASE 3; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CYTOKINE; DIHYDROERGOCRYPTINE; FLUOROCITRIC ACID; FRACTALKINE; GLYCOPROTEIN GP 120; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; IRRITANT AGENT; KYNURENIC ACID; LIPOPOLYSACCHARIDE; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NERVE GROWTH FACTOR; NERVE PROTEIN; PROSTAGLANDIN; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; ZYMOSAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ALLODYNIA; ASTROCYTE; AUTONOMIC DENERVATION; BLOOD BRAIN BARRIER; CANCER PAIN; CANCER PATIENT; CELL MIGRATION; CELL WALL; CHRONIC PAIN; CITRIC ACID CYCLE; CYTOKINE PRODUCTION; DEMYELINATION; EDEMA; ERYTHEMA; FEVER; FIBROBLAST; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERALGESIA; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGE; MAST CELL; MICROGLIA; NERVE CELL; NERVE CONDUCTION; NERVE ENDING; NERVE EXCITABILITY; NERVE INJURY; NEUROPATHIC PAIN; NEUTROPHIL; NOCICEPTION; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCHWANN CELL; SCIATIC NERVE; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD INFECTION; SPINAL CORD INJURY; TETANIC SPASM; UPREGULATION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; HYPERALGESIA; INFLAMMATION; NEURALGIA; NEUROGLIA; PAIN; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 44449119042     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2008.03.009     Document Type: Review

References (178)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., and Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 7947-7952
2. Aicher S.A., Sharma S., Cheng P.Y., and Pickel V.M. The N-methyl-d-aspartate (NMDA) receptor is postsynaptic to substance P-containing axon terminals in the rat superficial dorsal horn. Brain Research 772 (1997) 71-81
3. Aloisi F., De Simone R., Columba-Cabezas S., and Levi G. Opposite effects of interferon-gamma and prostaglandin E-2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. Journal of Neuroscience Research 56 (1999) 571-580
4. Araque A., Sanzgiri R.P., Parpura V., and Haydon P.G. Astrocyte-induced modulation of synaptic transmission. Canadian Journal of Physiology and Pharmacology 77 (1999) 699-706
5. Arruda J.L., Colburn R.W., Rickman A.J., Rutkowski M.D., and DeLeo J.A. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Molecular Brain Research 62 (1998) 228-235
6. Arruda J.L., Sweitzer S.A., Rutkowski M.D., and DeLeo J.A. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Research 879 (2000) 216-225
7. Asensio V.C., and Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends in Neurosciences 22 (1999) 504-512
8. Bao L., Zhu Y., Elhassan A.M., Wu Q.Y., Xiao B.G., Zhu J., and Lindgren J.U. Adjuvant-induced arthritis: IL-1 beta, IL-6 and TNF-alpha are up-regulated in the spinal cord. Neuroreport 12 (2001) 3905-3908
9. Bennett G.J. An animal-model of neuropathic pain-a review. Muscle & Nerve 16 (1993) 1040-1048
10. Bergjohnsen J., Paulsen R.E., Fonnum F., and Langmoen I.A. Changes in evoked-potentials and amino-acid content during fluorocitrate action studied in rat hippocampal cortex. Experimental Brain Research 96 (1993) 241-246
11. Brennan T.J., Vandermeulen E.P., and Gebhart G.F. Characterization of a rat model of incisional pain. Pain 64 (1996) 493-501
12. Brough D., Le Feuvre R.A., Iwakura Y., and Rothwell N.J. Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Molecular and Cellular Neuroscience 19 (2002) 272-280
13. Chacur M., Gutierrez J.M., Milligan E.D., Wieseler-Frank J., Britto L.R.G., Maier S.F., Watkins L.R., and Cury Y. Snake venom components enhance pain upon subcutaneous injection: an initial examination of spinal cord mediators. Pain 111 (2004) 65-76
14. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H.C., Tracey K.J., Maier S.F., and Watkins L.R. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 94 (2001) 231-244
15. Chapman G.A., Moores K., Harrison D., Campbell C.A., Stewart B.R., and Strijbos P. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. Journal of Neuroscience (2000) 20
16. Choi H.S., Ju J.S., Lee H.J., Kim B.C., Park J.S., and Ahn D.K. Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Brain Research Bulletin 59 (2003) 365-370
17. Clark A.K., Gentry C., Bradbury E.J., McMahon S.B., and Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. European Journal of Pain 11 (2007) 223-230
18. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., and Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. Journal of Neuroimmunology 79 (1997) 163-175
19. Colburn R.W., Rickman A.J., and DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Experimental Neurology 157 (1999) 289-304
20. Colpaert F.C. Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain 28 (1987) 201-222
21. Cui Y., Chen Y., Zhi J.L., Guo R.X., Feng J.Q., and Chen P.X. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Research 1069 (2006) 235-243
22. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 65 (2001) 1-105
23. DeLeo J.A., and Colburn R.W. Proinflammatory cytokines and glial cells: their role in neuropathic pain. In: Watkins L.R., and Maier S.F. (Eds). Cytokines and Pain. Progress in Inflammation Research (1999), Birkhauser Verlag, Basel 159-181
24. Deleo J.A., Colburn R.W., Nichols M., and Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. Journal of Interferon and Cytokine Research 16 (1996) 695-700
25. Deleo J.A., Colburn R.W., and Rickman A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Research 759 (1997) 50-57
26. Deleo J.A., Coombs D.W., Willenbring S., Colburn R.W., Fromm C., Wagner R., and Twitchell B.B. Characterization of a neuropathic pain model-sciatic cryoneurolysis in the rat. Pain 56 (1994) 9-16
27. Deleo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 (2004) 40-52
28. Deleo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
29. Dong Y.S., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
30. Dorazil-Ddudzik M., Mika J., Schafer M.K.H., Li Y.Z., Obara I., Wordliczek J., and Przewlocka B. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesthesia and Analgesia 98 (2004) 1566-1573
31. Ehlers M.R.W. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes and Infection 2 (2000) 289-294
32. Eliav E., Herzberg U., Ruda M.A., and Bennett G.J. Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain 83 (1999) 169-182
33. Elmquist J.K., Breder C.D., Sherin J.E., Scammell T.E., Hickey W.F., Dewitt D., and Saper C.B. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. Journal of Comparative Neurology 381 (1997) 119-129
34. Feng P., Wilson Q.M., Meissler J.J., Adler M.W., and Eisenstein T.K. Increased sensitivity to Salmonella enterica serovar typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. Infection and Immunity 73 (2005) 7953-7959
35. Flatters S.J.L., Fox A.J., and Dickenson A.H. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Research 984 (2003) 54-62
36. Fu D., Guo Q.L., Ai Y.H., Cai H.W., Yan J.Q., and Dai R.P. Glial activation and segmental upregulation of interleukin-1 beta (IL-1 beta) in the rat spinal cord after surgical incision. Neurochemical Research 31 (2006) 333-340
37. Garrison C.J., Dougherty P.M., Kajander K.C., and Carlton S.M. Staining of glial fibrillary acidic protein (Gfap) in lumbar spinal-cord increases following a sciatic-nerve constriction injury. Brain Research 565 (1991) 1-7
38. Gazda L.S., Milligan E.D., Hansen M.K., Twining C.M., Poulos N.M., Chacur M., O'Connor K.A., Armstrong C., Maier S.F., Watkins L.R., and Myers R.R. Sciatic inflammatory neuritis 〈SIN〉: behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. Journal of the Peripheral Nervous System 6 (2001) 111-129
39. Guo L.H., Trautmann K., and Schluesener H.J. Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain. Journal of Neuroimmunology 163 (2005) 120-127
40. Hains B.C., and Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. Journal of Neuroscience 26 (2006) 4308-4317
41. Han Y.P., Tuan T.L., Wu H.Y., Hughes M., and Garner W.L. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-kappa B mediated induction of MT1-MMP. Journal of Cell Science 114 (2001) 131-139
42. Hansson E., and Ronnback L. Altered neuronal-glial signaling in glutamatergic transmission as a unifying mechanism in chronic pain and mental fatigue. Neurochemical Research 29 (2004) 989-996
43. Hashizume H., DeLeo J.A., Colburn R.W., and Weinstein J.N. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25 (2000) 1206-1217
44. Hassel B., Paulsen R.E., Johnsen A., and Fonnum F. Selective-inhibition of glial-cell metabolism in vivo by fluorocitrate. Brain Research 576 (1992) 120-124
45. Herzberg U., and Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. Journal of Neuroimmunology 116 (2001) 29-39
46. Holguin A., O'Connor K.A., Biedenkapp J., Campisi J., Wieseler-Frank J., Milligan E.D., Hansen M.K., Spataro L., Maksimova E., Bravmann C., Martin D., Fleshner M., Maier S.F., and Watkins L.R. HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-1 (nNOS). Pain 110 (2004) 517-530
47. Hughes P.M., Botham M.S., Frentzel S., Mir A., and Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37 (2002) 314-327
48. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., Hartmann D., Fahrenholz F., Postina R., Matthews V., Kallen K.J., Rose-John S., and Ludwig A. The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102 (2003) 1186-1195
49. Ignatowski T.A., Covey W.C., Knight P.R., Severin C.M., Nickola T.J., and Spengler R.N. Brain-derived TNFalpha mediates neuropathic pain. Brain Research 841 (1999) 70-77
50. Ji R.R. Peripheral and central mechanisms of inflammatory pain with special references to MAP kinase. Current Drug Targets Inflammatory Allergy 3 (2004) 299-303
51. Ji R.R., Kawasaki Y., Zhuang Z.Y., Wen Y.R., and Zhang Y.Q. Protein kinases as potential targets for treatment of pathological pain. Handbook Experimental Pharmacology 177 (2007) 351-381
52. Ji R.R., and Suter M.R. p38 MAPK, microglial signaling, and neuropathic pain. Molecular Pain 3 (2007) 33
53. Ji R.R., and Wen Y.R. Neural-glial interaction in the spinal cord for the development and maintenance of nerve injury-induced neuropathic pain. Drug Development Research 67 (2006) 331-338
54. Ji R.R., and Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiology of Disease 8 (2001) 1-10
55. Jin S.X., Zhuang Z.Y., Woolf C.J., and Ji R.R. P38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. Journal of Neuroscience 23 (2003) 4017-4022
56. Johnston I.N., and Westbrook R.F. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia. Behavioural Brain Research 156 (2005) 75-83
57. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
58. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., and Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Molecular and Cellular Biology 20 (2000) 4106-4114
59. Kagan B.L., Baldwin R.L., Munoz D., and Wisnieski B.J. Formation of ion-permeable channels by tumor-necrosis-factor-alpha. Science 255 (1992) 1427-1430
60. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., and Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. Journal of Biological Chemistry 282 (2007) 14975-14983
61. Kim S.H., and Chung J.M. An experimental-model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
62. Kofuji P., and Newman E.A. Potassium buffering in the central nervous system. Neuroscience 129 (2004) 1045-1056
63. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 19 (1996) 312-318
64. Kumar S., Boehm J., and Lee J.C. p38 map kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature Reviews Drug Discovery 2 (2003) 717-726
65. Laming P.R., Kimelberg H., Robinson S., Salm A., Hawrylak N., Muller C., Roots B., and Ng K. Neuronal-glial interactions and behaviour. Neuroscience and Biobehavioral Reviews 24 (2000) 295-340
66. Lan L., Yuan H., Duan L., Cao R., Gao B., Shen J., Xiong Y.F., Chen L.W., and Rao Z.R. Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat. Neuroscience Research 57 (2007) 112-119
67. Ledeboer A., Gamanos M., Lai W., Martin D., Maier S.F., Watkins L.R., and Quan N. Involvement of spinal cord nuclear factor kappa B activation in rat models of proinflammatory cytokine-mediated pain facilitation. European Journal of Neuroscience 22 (2005) 1977-1986
68. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., and Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
69. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., and Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 8514-8519
70. Lin T., Li K., Zhang F.Y., Zhang Z.K., Light A.R., and Fu K.Y. Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models. Journal of Neuroimmunology 192 (2007) 40-48
71. Lindia J.A., McGowan E., Jochnowitz N., and Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. Journal of Pain 6 (2005) 434-438
72. Liu W., Wang C.H., Cui Y., Mo L.Q., Zhi J.L., Sun S.N., Wang Y.L., Yu H.M., Zhao C.M., Feng J.Q., and Chen P.X. Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neuroscience Letters 410 (2006) 174-177
73. Liu X.G., and Sandkuhler J. Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-d-aspartic acid receptor blockage. Neuroscience Letters 191 (1995) 43-46
74. Liu X.G., and Sandkuhler J. Characterization of long-term potentiation of C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors. Journal of Neurophysiology 78 (1997) 1973-1982
75. Ludwig A., Berkhout T., Moores K., Groot P., and Chapman G. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. Journal of Immunology 168 (2002) 604-612
76. Ma J.Y., and Zhao Z.Q. The involvement of glia in long-term plasticity in the spinal dorsal horn of the rat. Neuroreport 13 (2002) 1781-1784
77. Mantyh P.W., Clohisy D.R., Koltzenburg M., and Hunt S.P. Molecular mechanisms of cancer pain. Nature Reviews Cancer 2 (2002) 201-209
78. Mao-Ying Q.L., Zhao J., Dong Z.Q., Wang J., Yu J., Yan M.F., Zhang Y.Q., Wu G.C., and Wang Y.Q. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochemical Biophysical Research Communication 345 (2006) 1292-1298
79. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nature Reviews Neuroscience 6 (2005) 521-532
80. Marriott I. The role of tachykinins in central nervous system inflammatory responses. Frontiers in Bioscience 9 (2004) 2153-2165
81. Maves T.J., Pechman P.S., Gebhart G.F., and Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 54 (1993) 57-69
82. Meller S.T., Dykstra C., Grzybycki D., Murphy S., and Gebhart G.F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal-cord of the rat. Neuropharmacology 33 (1994) 1471-1478
83. Meller S.T., Pechman P.S., Gebhart G.F., and Maves T.J. Nitric-oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 50 (1992) 7-10
84. Milligan E., Zapata V., Schoeniger D., Chacur M., Green P., Poole S., Martin D., Maier S.F., and Watkins L.R. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. European Journal of Neuroscience 22 (2005) 2775-2782
85. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., and Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Research 861 (2000) 105-116
86. Milligan E.D., O'Connor K.A., Armstrong C.B., Hansen M.K., Martin D., Tracey K.J., Maier S.F., and Watkins L.R. Systemic administration of CNI-1493, a p38 mitogen-activated protein kinase inhibitor, blocks intrathecal human immunodeficiency virus-1 gp120-induced enhanced pain states in rats. Journal of Pain 2 (2001) 326-333
87. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., and Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. Journal of Neuroscience 23 (2003) 1026-1040
88. Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O'Connor K.A., Verge G.M., Chapman G., Green P., Foster A.C., Naeve G.S., Maier S.F., and Watkins L.R. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. European Journal of Neuroscience 20 (2004) 2294-2302
89. Murphy P.G., Ramer M.S., Borthwick L., Gauldie J., Richardson P.M., and Bisby M.A. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. European Journal of Neuroscience 11 (1999) 2243-2253
90. Nakajima K., and Kohsaka S. Microglia: activation and their significance in the central nervous system. Journal of Biochemistry 130 (2001) 169-175
91. Nesic O., Lee J., Johnson K.M., Ye Z.M., Xu G.Y., Unabia G.C., Wood T.G., McAdoo D.J., Westlund K.N., Hulsebosch C.E., and Perez-Polo J.R. Transcriptional profiling of spinal cord injury-induced central neuropathic pain. Journal of Neurochemistry 95 (2005) 998-1014
92. Obata H., Eisenach J.C., Hussain H., Bynum T., and Vincler M. Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. Journal of Pain 7 (2006) 816-822
93. Obraja O., Rathee P.K., Lips K.S., Dister C., and Kress M. IL-1β potentiates heat-activated currents in rat sensory neurons: involvement of IL-1R1, tyrosine kinase, and protein kinase C. The FASEB Journal 16 (2002) 1497-1503
94. Onda A., Hamba M., Yabuki S., and Kikuchi S. Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine 27 (2002) 1618-1624
95. Ono K., and Han J.H. The p38 signal transduction pathway-activation and function. Cellular Signalling 12 (2000) 1-13
96. Parkitna R.J., Korostynski M., Kaminska-Chowaniec D., Obara I., Mika J., Przewlocka B., and Przewlocki R. Comparison of gene expression profiles in neuropathic and inflammatory pain. Journal Physiology Pharmacology 57 (2006) 401-414
97. Paulsen R.E., Contestabile A., Villani L., and Fonnum F. An in vivo model for studying function of brain-tissue temporarily devoid of glial-cell metabolism-the use of fluorocitrate. Journal of Neurochemistry 48 (1987) 1377-1385
98. Peng X.M., Zhou Z.G., Glorioso J.C., Fink D.J., and Mata M. Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Annals of Neurology 59 (2006) 843-851
99. Pickering M., Cumiskey D., and O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 90 (2005) 663-670
100. Popovich P.G. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Neural Plasticity and Regeneration (2000) 43-58
101. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. Journal of Comparative Neurology 377 (1997) 443-464
102. Portenoy R.K., and Lesage P. Management of cancer pain. Lancet 353 (1999) 1695-1700
103. Qiu Z.H., Sweeney D.D., Netzeband J.G., and Gruol D.L. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. Journal of Neuroscience 18 (1998) 10445-10456
104. Raghavendra V., Agrewala J.N., and Kulkarni S.K. Melatonin reversal of lipopolysaccharides-induced thermal and behavioral hyperalgesia in mice. European Journal of Pharmacology 395 (2000) 15-21
105. Raghavendra V., and Deleo J.A. The role of astrocytes and microglia in persistent pain. In: Hertz L. (Ed). Non-Neuronal Cells in the Nervous System: Function and Dysfunction (2003), Elsevier, Amsterdam 951-966
106. Raghavendra V., Rutkowski M.D., and DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. Journal of Neuroscience 22 (2002) 9980-9989
107. Raghavendra V., Tanga F., and DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. Journal of Pharmacology and Experimental Therapeutics 306 (2003) 624-630
108. Raghavendra V., Tanga F.Y., and DeLeo J.A. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29 (2004) 327-334
109. Raghavendra V., Tanga R.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. European Journal of Neuroscience 20 (2004) 467-473
110. Ramer M.S., Murphy P.G., Richardson P.M., and Bisby M.A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 78 (1998) 115-121
111. Reeve A.J., Patel S., Fox A., Walker K., and Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. European Journal of Pain 4 (2000) 247-257
112. Ren W.H., Guo J.D., Cao H., Wang H., Wang P.F., Sha H., Ji R.R., Zhao Z.Q., and Zhang Y.Q. Is endogenous d-serine in the rostral anterior cingulate cortex necessary for pain-related negative affect?. Journal of Neurochemistry 96 (2006) 1636-1647
113. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behavior and Immunity 17 (2003) 13-19
114. Robinson A.P., White T.M., and Mason D.W. Macrophage heterogeneity in the rat as delineated by 2 monoclonal-antibodies Mrc Ox-41 and Mrc Ox-42, the latter recognizing complement receptor type-3. Immunology 57 (1986) 239-247
115. Saha R.N., and Pahan K. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. Journal of Neurochemistry 86 (2003) 1057-1071
116. Sandkuhler J., and Liu X.G. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. European Journal of Neuroscience 10 (1998) 2476-2480
117. Schafers M., Sorkin L.S., and Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 104 (2003) 579-588
118. Schaible, H.G., Ebersberger, A., Von Banchet, G.S., 2002. Mechanisms of pain in arthritis. In: Neuroendocrine Immune Basis of the Rheumatic Diseases Ii, Proceedings, pp. 343-354.
119. Schneider-Schaulies J., Schneider-Schaulies S., Brinkman R., Tas P., Halbrugge M., Walter U., Holmes H.C., and terMeulen V. Virology 191 (1992) 765-772
120. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., and Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. Journal of Neuroscience 19 (1999) 10886-10897
121. Seltzer Z., Dubner R., and Shir Y. A novel behavioral-model of neuropathic pain disorders produced in rats by partial sciatic-nerve injury. Pain 43 (1990) 205-218
122. Sluka K.A., Bailey K., Bogush J., Olson R., and Ricketts A. Treatment with either high or low frequency TENS reduces the secondary hyperalgesia observed after injection of kaolin and carrageenan into the knee joint. Pain 77 (1998) 97-102
123. Solari R., Smithers N., Kennard N., Ray K., and Grenfell S. Receptor-mediated endocytosis and intracellular fate of interleukin-1. Biochemical Pharmacology 47 (1994) 93-101
124. Song P., and Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neuroscience Research 39 (2001) 281-286
125. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Progress in Neurobiology 58 (1999) 233-247
126. Stoll G., Jander S., and Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. Journal of the Peripheral Nervous System 7 (2002) 13-27
127. Sun S., Cao H., Han M., Li T.T., Pan H.L., Zhao Z.Q., and Zhang Y.Q. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monarthritis. Pain 129 (2007) 64-75
128. Sun S., Cao H., Han M., Li T.T., Zhao Z.Q., and Zhang Y.Q. Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis. Brain Research Bulletin 75 (2008) 83-93
129. Sun S., Chen W.L., Wang P.F., Zhao Z.Q., and Zhang Y.Q. Disruption of glial function enhances electroacupuncture analgesia in arthritic rats. Experimental Neurology 198 (2006) 294-302
130. Sun S., Mao-Ying Q.L., Cao H., Li T.T., Han M., Pan H.L., Wang Y.Q., Zhao Z.Q., and Zhang Y.Q. Is functional state of spinal microglia involved in the anti-allogynic and anti-hyperalgesic effects of electroacupuncture in rat model of monarthritis?. Neurobiology of Disease 26 (2007) 558-568
131. Sung C.S., Wen Z.H., Chang W.K., Ho S.T., Tsai S.K., Chang Y.C., and Wong C.S. Intrathecal interleukin-beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Research 1015 (2004) 145-153
132. Svendsen F., Tjolsen A., and Hole K. AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. Neuroreport 9 (1998) 1185-1190
133. Sweitzer S., Martin D., and Deleo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
134. Sweitzer S.M., Colburn R.W., Rutkowski M., and DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1 beta expression that correlates with pain behavior in the rat. Brain Research 829 (1999) 209-221
135. Sweitzer S.M., and DeLeo J.A. The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model. Journal of Pain 3 (2002) 360-368
136. Sweitzer S.M., Schubert P., and DeLeo J.A. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. Journal of Pharmacology and Experimental Therapeutics 297 (2001) 1210-1217
137. Sykova E. Glia and volume transmission during physiological and pathological states. Journal of Neural Transmission 112 (2005) 137-147
138. Tai Y.H., Wang Y.H., Wang J.J., Tao P.L., Tung C.S., and Wong C.S. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain 124 (2006) 77-86
139. Tanga F.Y., Nutile-McMenemy N., and DeLeo J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 5856-5861
140. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochemistry International 45 (2004) 397-407
141. Tawfik V.L., Nutile-McMenemy N., LaCroix-Fralish M.L., and Deleo J.A. Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Brain Behavior and Immunity 21 (2007) 238-246
142. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. Journal of Immunology 166 (2001) 7527-7533
143. Tran P.B., and Miller R.J. Chemokine receptors: signposts to brain development and disease. Nature Reviews Neuroscience 4 (2003) 444-455
144. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends in Neurosciences 28 (2005) 101-107
145. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., and Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45 (2004) 89-95
146. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X(4) receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
147. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., and Wagner H. HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway. Journal of Biological Chemistry 277 (2002) 15107-15112
148. van der Goot F.G., Pugin J., Hribar M., Fransen L., Dunant Y., De Baetselier P., Bloc A., and Lucas R. Membrane interaction of TNF is not sufficient to trigger increase in membrane conductance in mammalian cells. FEBS Letters 460 (1999) 107-111
149. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naevel G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. European Journal of Neuroscience 20 (2004) 1150-1160
150. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., Tieu K., and Przedborski S. The role of glial cells in Parkinson's disease. Current Opinion in Neurology 14 (2001) 483-489
151. Vit J.P., Ohara P.T., Tien D.A., Fike J.R., Eikmeier L., Beitz A., Wilcox G.L., and Jasmin L. The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception. Pain 120 (2006) 188-201
152. Vitkovic L., Bockaert J., and Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. Journal of Neurochemistry 74 (2000) 457-471
153. Wagner R., Heckman H.M., and Myers R.R. Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent. Pain 77 (1998) 173-179
154. Wang Z.Y., Zhang Y.Q., and Zhao Z.Q. Inhibition of tetanically sciatic stimulation-induced LTP of spinal neurons and Fos expression by disrupting glutamate transporter GLT-1. Neuropharmacology 51 (2006) 764-772
155. Watanabe T., Yamamoto T., Abe Y., Saito N., Kumagai T., and Kayama H. Differential activation of microglia after experimental spinal cord injury. Journal of Neurotrauma 16 (1999) 255-265
156. Watkins L.R., Hutchinson M.R., Johnston I.N., and Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends in Neurosciences 28 (2005) 661-669
157. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., and Maier S.F. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behavior and Immunity 21 (2007) 131-146
158. Watkins L.R., and Maier S.F. Implications of immune-to-brain communication for sickness and pain. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 7710-7713
159. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiological Reviews 82 (2002) 981-1011
160. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nature Reviews Drug Discovery 2 (2003) 973-985
161. Watkins L.R., Martin D., Ulrich P., Tracey K.J., and Maier S.F. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71 (1997) 225-235
162. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends in Neurosciences 24 (2001) 450-455
163. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., and Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Research 654 (1994) 15-26
164. Wieseler-Frank J., Maier S.F., and Watkins L.R. Glial activation and pathological pain. Neurochemistry International 45 (2004) 389-395
165. Wilkinson M.F., Earle M.L., Triggle C.R., and Barnes S. Interleukin-1 beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. FASEB Journal 10 (1996) 785-791
166. Winkelstein B.A., Rutkowski M.D., Sweitzer S.M., Pahl J.L., and DeLeo J.A. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. Journal of Comparative Neurology 439 (2001) 127-139
167. Woolf C.J., and Mannion R.J. Neuropathic pain: a etiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
168. Woolf C.J., and Salter M.W. Neuroscience-neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1768
169. Yiangou Y., Facer P., Durrenberger P., Chessell I.P., Naylor A., Bountra C., Banati R.R., and Anand P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurology (2006) 6
170. Ying B., Lu N., Zhang Y.Q., and Zhao Z.Q. Involvement of spinal glia in tetanically sciatic stimulation-induced bilateral mechanical allodynia in rats. Biochemical and Biophysical Research Communications 340 (2006) 1264-1272
171. Yrjanhelkki J., Keinanen R., Pellikka M., Hokfelt T., and Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 15769-15774
172. Zhang J., Hoffert C., Vu H.K., Groblewski T., Ahmad S., and O'Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. European Journal of Neuroscience 17 (2003) 2750-2754
173. Zhang R.X., Liu B., Wang L.B., Ren K., Qiao H.T., Berman B.M., and Lao L.X. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118 (2005) 125-136
174. Zhang Z., Zhang Z.Y., Fauser U., and Schluesener H.J. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats. Neuroscience 152 (2008) 495-501
175. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M.W., Sarang S., Liu A.S., Hartley D.M., Du C.W., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
176. Zhuang Z.Y., Gerner P., Woolf C.J., and Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114 (2005) 149-159
177. Zhuang Z.Y., Kawasaki Y., Tan P.H., Wen Y.R., Huang J., and Ji R.R. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behavior and Immunity 21 (2007) 642-651
178. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., and Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. Journal of Neuroscience 26 (2006) 3551-3560